Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration

Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug
Administration
- Scientists from Pfizer, Amgen, and Biogen Idec Joined Caliper in Describing
the Applicability of the Platform to New Drug Applications and Quality by
Design Approaches -

HOPKINTON, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc.
(Nasdaq: CALP), a leading provider of life sciences tools, presented at a
training session for reviewers from the United States Food and Drug
Administration (FDA) on the benefits of the LabChip GX platform for high
throughput screening and characterization assays for biological drugs.

"We were pleased to accept the FDA's invitation to present our LabChip
platform to a large group of reviewers. We believe the LabChip platform will
accelerate the adoption of quality-by-design approaches that ultimately will
improve the safety profiles of new biologics and vaccines," said Kevin
Hrusovsky, CEO of Caliper Life Sciences. "Additionally, our discussions with
FDA officials indicate that Caliper's LabChip platform may have applications
for downstream manufacturing release assays and potentially as an inline
quality control technique."

Caliper invited pioneers in this field from Pfizer (PFE), Amgen (AMGN), and
Biogen Idec (BIIB) to describe their analytical approaches for biologics
characterization. These leading scientists presented to a standing-room-only
group of approximately 75 FDA personnel and described an industry-wide need
for analytical techniques that provide high throughput, predictive assessments
of biological product quality. This need is being addressed by Caliper's
LabChip GX platform, which provides high resolution analytical data on a time
scale that is approximately 70 times faster than conventional capillary
electrophoresis.

In addition to these presentations at the FDA, more than 60 scientists have
presented their research using Caliper's technologies this year at user
meetings attended by more than 600 current and potential customers.

About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies
enabling researchers in the life sciences industry to create life-saving and
enhancing medicines and diagnostic tests more quickly and efficiently. Caliper
is aggressively innovating new technology to bridge the gap between in vitro
assays and in vivo results and then translating those results into cures for
human disease. Caliper's portfolio of offerings includes state-of-the-art
microfluidics, lab automation & liquid handling, optical imaging technologies,
and discovery & development outsourcing solutions. For more information please
visit www.caliperLS.com.

LabChip is a registered trademark of Caliper Life Sciences, Inc.

SOURCE Caliper Life Sciences, Inc.

Melissa Bruno or Kristin Villiotte of Schwartz Communications,
+1-781-684-0770, caliper@schwartz-pr.com, for Caliper Life Sciences